Clinical Trial Update: Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

View source ↗

Summary

A clinical trial update comparing the safety of Efavirenz and Nevirapine in HIV-positive patients with mild baseline liver impairment and/or Hepatitis B or Hepa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B
• Hepatitis C

Drugs mentioned

• EFAVIRENZ (efavirenz)
• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Henan Provincial People's Hospital | Conditions: HIV Infections, Liver Toxicity | Status: UNKNOWN